+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke



Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke



Archives of Internal Medicine 166(4): 399-404



Clinical trials of conjugated equine estrogen (CEE) or estradiol vs placebo in postmenopausal women have found no effect or an elevated risk of myocardial infarction (MI) and stroke. The association of these end points with the use of esterified estrogen (EE) is unknown. We examined the risk of MI and stroke associated with current use of CEE, use of EE, or nonuse of hormones in a population-based case-control study in a health maintenance organization. Cases were all postmenopausal women with an incident MI (n = 1644) or stroke (n = 1080). Controls (n = 4205) consisted of a random sample of postmenopausal women without MI or stroke. Current use of postmenopausal hormones was assessed using a computerized pharmacy database. There was no difference in risk of MI or stroke associated with current use of CEE or EE compared with nonuse or for current use of CEE compared with EE. In analyses restricted to hormone users, there was a suggestion of higher ischemic stroke risk associated with CEE alone (without progestin) compared with EE alone (odds ratio, 1.57; 95% confidence interval, 0.98-2.53). There was also a suggestion that when initiated in the previous 6 months, CEE was associated with a higher risk of MI than EE (odds ratio, 2.33; 95% confidence interval, 0.93-5.82). Further study may be warranted of the effects of EE on the risk of cardiovascular end points.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012049922

Download citation: RISBibTeXText

PMID: 16505258

DOI: 10.1001/archinte.166.4.399


Related references

Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 26(12): 2807-2812, 2006

The Effect of Treatment with Conjugated Equine Estrogen Preparations on Estrogen Excretion in Male Subjects with Myocardial Infarction. Current Therapeutic Research, Clinical and Experimental 6: 35-49, 1964

The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women. Journal of Thrombosis and Haemostasis 4(8): 1701-1706, 2006

The Effect of Treatment with Conjugated Equine Estrogen Preparations on 17-Ketosteroid and Pregnanediol Excretion in Male Subjects with Myocardial Infarction. Current Therapeutic Research, Clinical and Experimental 6: 50-61, 1964

Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women. Human Reproduction 21(10): 2715-2720, 2006

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113(20): 2425-2434, 2006

Molecular characterization of a B-ring unsaturated estrogen: implications for conjugated equine estrogen components of premarin. Steroids 73(1): 59-68, 2007

Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women. Maturitas 79(1): 70-76, 2016

Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen. International Journal of Cancer 143(5): 1259-1268, 2018

The effect of estrogen on endotoxin response. III. The relationship between doses of conjugated equine estrogen and time course of anti-endotoxic potency. Masui. Japanese Journal of Anesthesiology 26(9): 995-1001, 1977

Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice. Endocrinology 153(12): 5706-5715, 2013

Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women. Circulation 106(14): 1771-1776, 2002

Acute coronary vascular and myocardial perfusion effects of conjugated equine estrogen in the anesthetized dog. Basic Research in Cardiology 93(6): 470-476, 1999

Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics 362(1): 98-107, 2017

Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. American Journal of Hypertension 26(10): 1210-1217, 2014